D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching

Am J Transplant. 2009 Feb;9(2):318-26. doi: 10.1111/j.1600-6143.2008.02491.x. Epub 2008 Dec 15.

Abstract

Numerous donor and recipient risk factors interact to influence the probability of survival after liver transplantation. We developed a statistic, D-MELD, the product of donor age and preoperative MELD, calculated from laboratory values. Using the UNOS STAR national transplant data base, we analyzed survival for first liver transplant recipients with chronic liver failure from deceased after brain death donors. Preoperative D-MELD score effectively stratified posttransplant survival. Using a cutoff D-MELD score of 1600, we defined a subgroup of donor-recipient matches with significantly poorer short- and long-term outcomes as measured by survival and length of stay (LOS). Avoidance of D-MELD scores above 1600 improved results for subgroups of high-risk patients with donor age >/=60 and those with preoperative MELD >/=30. D-MELD >/=1600 accurately predicted worse outcome in recipients with and without hepatitis C. There is significant regional variation in average D-MELD scores at transplant, however, regions with larger numbers of high D-MELD matches do not have higher survival rates. D-MELD is a simple, highly predictive tool for estimating outcomes after liver transplantation. This statistic could assist surgeons and their patients in making organ acceptance decisions. Applying D-MELD to liver allocation could eliminate many donor/recipient matches likely to have inferior outcome.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Child
  • Child, Preschool
  • Graft Survival
  • Histocompatibility Testing
  • Humans
  • Infant
  • Infant, Newborn
  • Liver Diseases / surgery*
  • Liver Transplantation / mortality*
  • Middle Aged
  • Models, Statistical*
  • Postoperative Complications*
  • Predictive Value of Tests
  • Prognosis
  • Survival Rate
  • Tissue Donors*
  • Young Adult